VASCULAR PARKINSONISM
Clinical trials for VASCULAR PARKINSONISM explained in plain language.
Never miss a new study
Get alerted when new VASCULAR PARKINSONISM trials appear
Sign up with your email to follow new studies for VASCULAR PARKINSONISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a multiple sclerosis drug help people with parkinsonism walk better?
Disease control CompletedThis study looks at whether dalfampridine, a drug already used for walking problems in multiple sclerosis, can improve mobility in people with vascular parkinsonism or Parkinson-plus syndromes. Participants who do not respond well to standard levodopa treatment will receive dalfa…
Matched conditions: VASCULAR PARKINSONISM
Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can a One-Time bone drug shield Parkinson's patients from fractures?
Prevention CompletedThis study tested whether a single infusion of zoledronic acid (Reclast) can prevent fractures in men and women aged 60 and older with Parkinson's disease or related conditions. Over 2,700 participants were randomly assigned to receive either the drug or a placebo, and were follo…
Matched conditions: VASCULAR PARKINSONISM
Phase: PHASE4 • Sponsor: California Pacific Medical Center Research Institute • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC